Found: 24
Select item for more details and to access through your institution.
Current Methods and Caveats to Risk Factor Assessment in Cutaneous Squamous Cell Carcinoma (cSCC): A Narrative Review.
- Published in:
- Dermatology & Therapy, 2022, v. 12, n. 2, p. 267, doi. 10.1007/s13555-021-00673-y
- By:
- Publication type:
- Article
Dapsone in Hidradenitis Suppurativa: A Systematic Review.
- Published in:
- Dermatology & Therapy, 2022, v. 12, n. 2, p. 285, doi. 10.1007/s13555-021-00674-x
- By:
- Publication type:
- Article
Topical Ectoine Application in Children and Adults to Treat Inflammatory Diseases Associated with an Impaired Skin Barrier: A Systematic Review.
- Published in:
- Dermatology & Therapy, 2022, v. 12, n. 2, p. 295, doi. 10.1007/s13555-021-00676-9
- By:
- Publication type:
- Article
Role of Interleukin 36 in Generalised Pustular Psoriasis and Beyond.
- Published in:
- Dermatology & Therapy, 2022, v. 12, n. 2, p. 315, doi. 10.1007/s13555-021-00677-8
- By:
- Publication type:
- Article
Photoprotection in Outdoor Sports: A Review of the Literature and Recommendations to Reduce Risk Among Athletes.
- Published in:
- Dermatology & Therapy, 2022, v. 12, n. 2, p. 329, doi. 10.1007/s13555-021-00671-0
- By:
- Publication type:
- Article
Exposome and Skin: Part 1. Bibliometric Analysis and Review of the Impact of Exposome Approaches on Dermatology.
- Published in:
- Dermatology & Therapy, 2022, v. 12, n. 2, p. 345, doi. 10.1007/s13555-021-00680-z
- By:
- Publication type:
- Article
Exposome and Skin. Part 2. The Influential Role of the Exposome, Beyond UVR, in Actinic Keratosis, Bowen's Disease and Squamous Cell Carcinoma: A Proposal.
- Published in:
- Dermatology & Therapy, 2022, v. 12, n. 2, p. 361, doi. 10.1007/s13555-021-00644-3
- By:
- Publication type:
- Article
Unmet Educational Needs and Clinical Practice Gaps in the Management of Generalized Pustular Psoriasis: Global Perspectives from the Front Line.
- Published in:
- Dermatology & Therapy, 2022, v. 12, n. 2, p. 381, doi. 10.1007/s13555-021-00661-2
- By:
- Publication type:
- Article
Assessment of Life Quality, Stress and Physical Activity Among Patients with Psoriasis.
- Published in:
- Dermatology & Therapy, 2022, v. 12, n. 2, p. 395, doi. 10.1007/s13555-021-00662-1
- By:
- Publication type:
- Article
Impact of Risankizumab on PASI90 and DLQI0/1 Duration in Moderate-to-Severe Psoriasis: A Post Hoc Analysis of Four Phase 3 Clinical Trials.
- Published in:
- Dermatology & Therapy, 2022, v. 12, n. 2, p. 407, doi. 10.1007/s13555-021-00660-3
- By:
- Publication type:
- Article
Development of a Predictive Model for Screening Patients with Psoriasis at Increased Risk of Psoriatic Arthritis.
- Published in:
- Dermatology & Therapy, 2022, v. 12, n. 2, p. 419, doi. 10.1007/s13555-021-00663-0
- By:
- Publication type:
- Article
Methoxy-Monobenzoylmethane Protects Skin from UV-Induced Damages in a Randomized, Placebo Controlled, Double-Blinded Human In Vivo Study and Prevents Signs of Inflammation While Improving the Skin Barrier.
- Published in:
- Dermatology & Therapy, 2022, v. 12, n. 2, p. 435, doi. 10.1007/s13555-021-00652-3
- By:
- Publication type:
- Article
Apremilast Prolongs the Time to First Biologic Therapy in Japanese Patients with Psoriasis.
- Published in:
- Dermatology & Therapy, 2022, v. 12, n. 2, p. 451, doi. 10.1007/s13555-021-00659-w
- By:
- Publication type:
- Article
Intensity of Local Skin Reactions During 5-Fluorouracil Treatment Related to the Number of Actinic Keratosis Lesions: A Post Hoc, Exploratory Analysis.
- Published in:
- Dermatology & Therapy, 2022, v. 12, n. 2, p. 467, doi. 10.1007/s13555-021-00668-9
- By:
- Publication type:
- Article
Ixekizumab 80 mg Every 2 Weeks Treatment Beyond Week 12 for Japanese Patients with Generalized Pustular Psoriasis and Erythrodermic Psoriasis.
- Published in:
- Dermatology & Therapy, 2022, v. 12, n. 2, p. 481, doi. 10.1007/s13555-021-00666-x
- By:
- Publication type:
- Article
Deucravacitinib in Moderate to Severe Psoriasis: Clinical and Quality-of-Life Outcomes in a Phase 2 Trial.
- Published in:
- Dermatology & Therapy, 2022, v. 12, n. 2, p. 495, doi. 10.1007/s13555-021-00649-y
- By:
- Publication type:
- Article
Effectiveness and Safety of Secukinumab for Psoriasis in a Real-World Clinical Setting in the Asia-Pacific and Middle East Regions: Results from the REALIA Study.
- Published in:
- Dermatology & Therapy, 2022, v. 12, n. 2, p. 511, doi. 10.1007/s13555-021-00675-w
- By:
- Publication type:
- Article
The Impact of Stress-Coping Strategies and the Severity of Psoriasis on Self-Esteem, Illness Acceptance and Life Satisfaction.
- Published in:
- Dermatology & Therapy, 2022, v. 12, n. 2, p. 529, doi. 10.1007/s13555-021-00669-8
- By:
- Publication type:
- Article
Validation of Patient Identification Algorithms for Atopic Dermatitis Using Healthcare Databases.
- Published in:
- Dermatology & Therapy, 2022, v. 12, n. 2, p. 545, doi. 10.1007/s13555-021-00670-1
- By:
- Publication type:
- Article
Efficacy of Risankizumab versus Secukinumab in Patients with Moderate-to-Severe Psoriasis: Subgroup Analysis from the IMMerge Study.
- Published in:
- Dermatology & Therapy, 2022, v. 12, n. 2, p. 561, doi. 10.1007/s13555-021-00679-6
- By:
- Publication type:
- Article
Facial Acne: A Randomized, Double-Blind, Placebo-Controlled Study on the Clinical Efficacy of a Symbiotic Dietary Supplement.
- Published in:
- Dermatology & Therapy, 2022, v. 12, n. 2, p. 577, doi. 10.1007/s13555-021-00664-z
- By:
- Publication type:
- Article
Clinical Utility of the 40-Gene Expression Profile (40-GEP) Test for Improved Patient Management Decisions and Disease-Related Outcomes when Combined with Current Clinicopathological Risk Factors for Cutaneous Squamous Cell Carcinoma (cSCC): Case Series.
- Published in:
- Dermatology & Therapy, 2022, v. 12, n. 2, p. 591, doi. 10.1007/s13555-021-00665-y
- By:
- Publication type:
- Article
Lentigo Maligna on a Difficult Location of the Face Treated with 5% Imiquimod: A Case Report of 2-Year Follow-Up.
- Published in:
- Dermatology & Therapy, 2022, v. 12, n. 2, p. 599, doi. 10.1007/s13555-021-00667-w
- By:
- Publication type:
- Article
Adalimumab Biosimilar-Induced Severe Paradoxical Palmoplantar Pustulosis in a Patient with Psoriasis and Psoriatic Arthritis Successfully Treated with Ixekizumab.
- Published in:
- Dermatology & Therapy, 2022, v. 12, n. 2, p. 605, doi. 10.1007/s13555-021-00672-z
- By:
- Publication type:
- Article